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Abstract  
Genetics has proven to be a powerful approach in neurodegenerative diseases research, resulting 
in the identification of numerous causal and risk variants. Previously, we introduced the NeuroX 
Illumina genotyping array, a fast and efficient genotyping platform designed for the investigation 
of genetic variation in neurodegenerative diseases. Here, we present its updated version, named 
NeuroChip. The NeuroChip is a low cost, custom-designed array containing a tagging variant 
backbone of about 306,670 variants complemented with a manually curated custom content 
comprised of 179,467 variants implicated in diverse neurological diseases, including Alzheimer’s 
disease, Parkinson’s disease, Lewy body dementia, amyotrophic lateral sclerosis, frontotemporal 
dementia, progressive supranuclear palsy, corticobasal degeneration and multiple system 
atrophy. The tagging backbone was chosen because of the low cost and good genome-wide 
resolution; the custom content can be combined with other backbones, like population or drug 
development arrays. Using the NeuroChip, we can accurately identify rare variants and impute 
over 5.3 million common SNPs from the latest release of Haplotype Reference Consortium. In 
summary, we describe the design and usage of the NeuroChip array, and show its capability of 
detecting rare pathogenic variants in numerous neurodegenerative diseases. The NeuroChip has 
a more comprehensive and improved content, which makes it a reliable, high-throughput, cost-
effective screening tool for genetic research and molecular diagnostics in neurodegenerative 
diseases.  
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1. Introduction 
Neurodegenerative diseases are a major burden to the aging world population and currently 
these diseases are incurable and irreversible. Common and rare genetic alterations in many 
genes have been identified as disease-causing or contributing to the development of 
neurodegeneration (Naj et al., 2017, Singleton and Hardy, 2016). To date, there are four main 
uses of genetics: 1) to confirm a clinical diagnosis by identifying a causal mutation, 2) to identify 
risk variants and disease modifiers that influence risk for disease, 3) to increase knowledge of the 
molecular pathobiology of disease in the hopes of identifying therapeutic targets, and 4) to 
improve patient selection for pathway-specific clinical trial design. A reliable, high-throughput 
and cost-effective platform that can rapidly conduct these functions could therefore be 
immensely valuable to the field.  
Previously, we presented the NeuroX array, which was a collaborative effort with the objective 
of designing a genotyping platform that would allow rapid genetic characterization of samples in 
the context of genetic mutations and risk factors associated with common neurodegenerative 
diseases (Nalls et al., 2015). This was an exonic array (or exome chip) based on the Infinium 
HumanExome Beadchip v1.1 containing 242,901 exome-focused variants as well as 24,706 
custom variants focusing on neurological diseases. The NeuroX array has already been 
successfully used in dozens of studies (Barber et al., 2017, Carrasquillo et al., 2016, Ghani et al., 
2015, Nalls et al., 2016, Rosenthal et al., 2016). However, due to the ďaĐkďoŶe’s focus on rare 
exonic variation, common non-exonic variants were largely missed, resulting in a modest 
genome-wide resolution and only partial capture of the known low frequency exonic variation. 
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Additionally, the number of genotype-phenotype associations and pathogenic variants keeps 
expanding, so there was a continued need for updating this useful platform. 
Here, we report on an updated version of NeuroX, named NeuroChip. The NeuroChip backbone 
is based on a genome-wide genotyping array (Infinium HumanCore-24 v1.0) containing 306,670 
tagging variants and a custom content that has been updated and extended with 
neurodegenerative disease-related custom content consisting of 179,467 variants. This backbone 
was chosen because of the low cost and good genome-wide resolution. This backbone is flexible 
and other arrays can be used with this custom content, such as population or drug development 
arrays (Infinium Multi-Ethnic, Infinium DrugDev). The NeuroChip allows to accurately identify 
rare neurodegenerative candidate variants and impute over 5.3 million common variants. Its 
approximate cost of ~$40 per sample is a fraction of the price of next-generation whole exome 
or whole genome sequencing, and therefore provides a valuable, high-throughput screening tool 
for loci and variants implicated in neurodegenerative diseases. Further, this array can be used as 
a tool to prioritize samples for more expensive genome sequencing approaches.  
 
2. Methods 
2.1 NeuroChip array design 
The backbone of the array, the Infinium HumanCore-24 v1.0, contains 306,670 highly informative 
tagging SNPs which can be used for high-throughput and high-quality imputation of genome-
wide variants across diverse populations (Illumina). In addition, the chip contains 179,467 custom 
disease-associated variants (Table 1) covering neurodegenerative diseases including: Alzheiŵer’s 
disease ;ADͿ, ParkiŶsoŶ’s disease (PD), Lewy body dementia (LBD), frontotemporal dementia 
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(FTD), amyotrophic lateral sclerosis (ALS), progressive supranuclear palsy (PSP), corticobasal 
degeneration (CBD) and multiple system atrophy (MSA). The custom-content has been curated 
by members of the International Parkinson’s Disease Genomics Consortium (IPDGC) to include 
common variants and rare mutations implicated in neurological diseases as reported in the 
Human Gene Mutation Database (HGMD Professional 2016.4, QIAGEN), the NHGRI GWAS 
Catalog (https://www.ebi.ac.uk/gwas/), the Parkinson’s Disease Mutation Database 
(http://www.molgen.vib-ua.be/PDMutDB), the Alzheimer’s Disease and Frontotemporal 
Dementia Database (http://www.molgen.ua.ac.be/admutations/), and based on literature 
review as well as own data; particularly in the latter case, collaborators submitted variants that 
were identified in multiple ongoing (or completed) unpublished projects, including variants from 
genome-wide association (GWA), whole exome, whole genome, targeted sequencing studies and 
systems biology studies. See Supplementary Table 1 for the complete content of the NeuroChip 
array.  
 
2.2 NeuroChip array genotyping  
We genotyped a cohort of 273 neurologically normal controls as per the manufacturer's 
instructions (Illumina) to generate pilot NeuroChip data. These samples have been collected by 
the North American Brain Expression Consortium (NABEC) and described elsewhere (Hernandez 
et al., 2012). In total, 183 males and 90 females were included. All subjects reported European 
ancestry and had no neurological disease based on pathological evaluation. All samples were 
obtained from North American brain banks. To assess the reproducibility of the NeuroChip, we 
genotyped 15 samples twice in separate experiments.  
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Raw data files were imported into GenomeStudio (version 2.0, Illumina). For initial quality 
control, we confirmed accurate, high quality genotyping using a call rate threshold of > 95%. We 
reclustered the samples using a GenCall threshold of 0.15 and recalled all variants. The 
genotyping cluster file based on ~3,500 individuals of ongoing projects is available in the 
Supplementary Materials (Supplementary File 1). The mean call rate post-reclustering was 0.992 
(range: 0.954-0.995). The data were exported from GenomeStudio using the Illumina-to-PLINK 
module 2.1.4 and imported into PLINK (version 1.90) (Chang et al., 2015). Next, we checked 
individuals for discrepancies between reported sex and genotypic sex, cryptic relatedness (PIHAT 
<0.05), and heterogeneity contamination, and found that no samples failed this quality control 
step. Genotype data of the 273 neurologically normal controls are deposited in the European 
Genome-Phenome Archive under submission number EGAS0000XXX. 
 
2.3 NeuroChip content annotation 
Annotation of the NeuroChip content was performed using ANNOVAR (Wang et al., 2010). For 
each variant, a gene-based annotation, in silico impact scores, and frequencies from public 
databases were obtained. To predict the impact scores, the following algorithms were used: SIFT 
(Kumar et al., 2009), Polyphen-2 (Adzhubei et al., 2010), and CADD (Kircher et al., 2014). 
Population frequencies were obtained from the Exome Aggregation Consortium (version 0.3.1) 
(http://exac.broadinstitute.org/) containing 60,706 individuals. Additionally, all variants were 
investigated for their presence in the Human Gene Mutation Database (HGMD, accessed 20 
December 2016). Variants associated with a common neurodegenerative syndrome (AD, ALS, 
FTD and PD) were manually curated and are summarized in Supplementary Table 2.  
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2.4 NeuroChip content imputation  
After confirming high-quality genotyping (call rate >95%) and European ancestry in all individuals 
(based on 1000Genomes clustering) (Genomes Project et al., 2015), we performed imputation 
using the Michigan imputation server, according to established guidelines 
(https://imputationserver.sph.umich.edu) (Das et al., 2016). In brief, genotypes were prepared 
for imputation using provided scripts (HRC-1000G-check-bim.pl), which compares variant ID, 
strand, and allele frequencies to the haplotype reference panel (HRC version r1.1, April 2016) 
(McCarthy et al., 2016). A total of 332,015 autosomal SNPs were submitted to the Imputation 
Server using ShapeIT (v2.r790).  
 
2.5 APOE allele genotyping 
To determine the accuracy of APOE allele predictions, we performed Taqman genotyping of two 
nonsynonymous APOE SNPs (rs7412 and rs429358) on an Applied Biosystems ViiA 7 Real-Time 
PCR System using an established protocol (Federoff et al., 2012). 272 out of 273 control samples 
had sufficient DNA for genotyping. Allelic discrimination was conducted using QuantStudio 
software (version 1.3, Thermo Fisher Scientific, Carlsbad, CA, USA). Taqman genotype results 
were then compared to the corresponding results for the same SNPs generated using the 
NeuroChip. Given the importance of APOE, NeuroChip was designed so that rs7412 is genotyped 
by four separate probes (three of which performed well: rs7412, seq-rs7412-B1, seq-rs7412-B3). 
Similarly, rs429358 was genotyped by five separate bead probes (two of which performed well: 
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seq-rs429358-T2, seq-rs429358-T3). This redundancy ensures accurate APOE genotyping by the 
NeuroChip platform.  
 
3. Results 
3.1 NeuroChip content overview 
In total, the NeuroChip array contains 473,442 autosomal variants, 11,840 sex chromosomal 
variants, and 160 mitochondrial variants. Additionally, 16,274 NeuroChip variants detect small 
insertions or deletions (Table 1). The overlap between NeuroX and NeuroChip is small (n= 19,289 
variants) due to the difference in the design of the backbone; the NeuroX array is focused on 
exonic content, whereas the NeuroChip is focused on genome wide tagging content.  
 
3.2 NeuroChip pathogenic variant content 
In total, the NeuroChip harbors 8,086 disease-associated variants that are included in HGMD, a 
professionally curated database of published genetic variants that have been linked to inherited 
human diseases (neurological and non-neurological). The NeuroChip HGMD content includes 
1,233 variants (1,202 SNPs and 31 indels) linked to common neurodegenerative syndromes (see 
Supplementary Figure 1 for a comparison between NeuroX and NeuroChip). In this content, after 
manually curation, 601 variants are associated with ALS or FTD, 348 with PD, and 284 with AD. 
Figure 1 shows the number of pathogenic variants per gene covered in common 
neurodegenerative syndromes. Detailed, manually curated and annotated variant lists for the 
abovementioned neurodegenerative disease categories are documented in Supplementary Table 
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2. These annotated lists can be used as filters to quickly screen for known mutations and risk 
variants. 
 
3.3 NeuroChip genotyping results 
Genotyping reproducibility 
Of the 15 technical replicates, all samples yielded high quality, reproducible genotyping results. 
The mean concordance rate per technical replicate was 0.9996 (range=0.9991-0.9999); on 
average, 190 variants (range=27-435) differed per technical replicate (0.04% of the total included 
variants on the array). Across the 15 technical replicates, 1,978 unique variants were discordant, 
of which 749 (37.9%) were from the backbone and 1,229 (62.1%) were from the custom content 
(Supplementary Table 3). 
 
Imputation 
Imputation of autosomal variants was performed on a series of 273 European descent individuals 
using the haplotype reference panel (McCarthy et al., 2016) containing 39,235,157 variants, all 
with an estimated minor allele count of >= 5 in 32,488 individuals. Initial pre-imputation filtering 
of the NeuroChip data (including removing duplicates and non-overlapping variants, switch 
strands, and updating position) resulted in 332,015 variants. After imputation, 11,879,345 
variants were obtained with an imputation R2 of > 0.30. Filtering based on MAF > 0.05, Hardy-
Weinberg Equilibrium p-value of > 1e-6 resulted in 5,316,028 variants. In this imputed dataset, 
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we successfully and reliably identified 22 of 26 PD risk alleles and 19 of the 21 AD GWA SNPs 
(Lambert et al., 2013, Nalls et al., 2014).  
 
Genotype accuracy 
GenTrain scores were calculated for all NeuroChip variants using GenomeStudio (version 2, 
lllumina). The GenTrain score is a statistical score based on the shapes of the different allelic 
clusters and their relative distance to each other (Illumina). Typically, GenTrain scores > 0.7 are 
considered high quality genotypes. Previously, GenTrain scores of the NeuroX showed that 
genotyping quality in the custom content was lower compared to the backbone (Nalls et al., 
2015). However, preliminary NeuroChip data from several ongoing projects (based on ~3,500 
individuals) reveals that the backbone and the custom content have a high comparable average 
score (0.819 and 0.820, respectively), indicating high genotyping accuracy (Supplementary 
Figures 2 & 3). 
 
Validation of APOE genotyping 
APOE alleles are important genetic risk factors for both AD and LDB, but genotyping of this region 
is complicated by high GC content (Singleton et al., 2002, Strittmatter and Roses, 1996). For this 
reason, we chose to validate the accuracy of APOE allele genotyping by comparing Taqman 
results with genotype predictions from the NeuroChip (Supplementary Table 4). Taqman 
genotyping for rs7412 and rs429358 was successful in all 272 samples. NeuroChip genotyping for 
both SNPs was successful in 265 out of these 272 controls (97.4%). Five samples were discordant 
for APOE allele genotyping between Taqman and NeuroChip, representing 1.9% of our test 
  
12 
cohort (n = 265 samples). The performance of the NeuroChip for APOE genotyping was 
significantly better than the original NeuroX platform, which was unable to reliably detect rs7412 
and rs429358 genotypes (Ghani et al., 2015, Nalls et al., 2015).  
 
4. Discussion 
The main goal was to develop a genotyping array that allows a rapid, high-throughput 
identification of common and rare single nucleotide variants in the human genome. Affordable 
screening of large cohorts for disease-associated variants allows for testing of polygenic 
inheritance that could explain the diversity of clinical and pathological characteristics of 
neurodegenerative diseases. NeuroChip genotyping is currently much faster and cheaper than 
next-generation sequencing methods. The NeuroChip is estimated to cost ~ $40/sample, which 
is currently less than ~ 10% and ~ 5% of the cost of whole exome sequencing and whole genome 
sequencing, respectively. 
We have designed, implemented and validated the NeuroChip array platform for high throughput 
genotyping. However, it is important to recognize the limitations of this approach. Like all 
genotyping arrays, NeuroChip does not detect novel sequence changes. It is also not possible to 
genotype variants in complex genomic regions (e.g. due to pseudogenes) or to identify repeat 
expansions due to the difficulty in designing reliable probes. Nevertheless, every effort was made 
to improve genotyping calling in NeuroChip. For example, it was recognized that the APOE locus 
performed poorly on the original NeuroX platform (Ghani et al., 2015). Given the importance of 
this genomic region in neurodegeneration, the revised NeuroChip probe design included multiple 
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probes for SNPs in this region. This led to reliable APOE allele calling with a concordance rate of 
98.1% between NeuroChip and Taqman. 
In conclusion, we describe the design and usage of the NeuroChip array, which has a more 
comprehensive and improved content compared to NeuroX. We discussed its capability of 
detecting rare variants associated with numerous neurodegenerative diseases and demonstrated 
that imputation of the NeuroChip content results in a high and robust genome-wide common 
variant coverage.  
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TABLES AND FIGURES 
Table 1. Differences between NeuroX and the NeuroChip.  
Variant Description NeuroX NeuroChip Comparison 
Total variants (pre-QC)  267,607 486,137 +218,530 
Backbone 242,901 306,670 +63,769 
Custom-content variants 24,706 179,467 +154,761 
Indels 200 16,259 +16,059 
Autosomal variants 261,477 473,442 +211,965 
Coding variants 226,104 88,560 -137,544 
Sex chromosomal variants 5,906 11,840 +5,934 
Mitochondrial variants 219 160 -59 
Variants with MAF < 0.05 219,093 227,448 +8,355 
Variants with MAF < 0.001 179,500 154,953 -24,547 
MAF = minor allele frequency
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Figure 1. 
 
 
 
Overview of the number of HGMD disease associated variants that are present on the NeuroChip. AD = Alzheimer’s disease, ALS = 
amyotrophic lateral sclerosis, FTD = frontotemporal dementia, and PD = Parkinson’s disease 
 1 
NeuroChip, an updated version of the NeuroX genotyping platform to 
rapidly screen for variants associated with neurological diseases 
 
SUPPLEMENTARY MATERIAL 
 
International Parkinson’s Disease Genomics Consortium (IPDGC) members ……….………. page 2 
COURAGE-PD Consortium members ……………………………………………………….……………………. page 5 
Supplementary Figure 1 ………………………………………………………..………………………………………. page 6 
Supplementary Figure 2 …………………………………………………………..……………………………………. page 7 
Supplementary Figure 3 ……………………………………………………..…………………………………………. page 8 
Supplementary Table 1: NeuroChip Content  -> see Supplementary_Table_1.txt.gz file 
Supplementary Table 2: Annotated HGMD Variants -> see Supplementary_Table_2.xlsx file 
Supplementary Table 3: Discordant Variants  -> see Supplementary_Table_3.xlsx file 
Supplementary Table 4: APOE Genotyping   -> see Supplementary_Table_4.xlsx file 
Supplementary File 1: Genotyping Cluster File  -> see attached NeuroChip.egt file 
 
  
 2 
IPDGC consortium members and affiliations: 
Alastair J Noyce (Department of Molecular Neuroscience, UCL, London, UK), Alexis Brice (Institut 
du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne 
Universités, UPMC University Paris 06, UMR S 1127, AP-HP, Pitié-Salpêtrière Hospital, Paris, 
France), Anamika Giri (Department for Neurodegenerative Diseases, Hertie Institute for Clinical 
Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative 
Diseases, Tübingen, Germany), Angelika Oehmig (Department for Neurodegenerative Diseases, 
Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for 
Neurodegenerative Diseases, Tübingen, Germany), Arianna Tucci (Department of Molecular 
Neuroscience, UCL Institute of Neurology, London, UK), Aude Nicolas (Laboratory of 
Neurogenetics, National Institute on Aging, Bethesda, MD, USA), Claudia Schulte (Department 
for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research), Mark R Cookson 
(Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA), Cornelis 
Blauwendraat (Laboratory of Neurogenetics, National Institute on Aging, Bethesda, USA), Demis 
Kia (UCL Genetics Institute; and Department of Molecular Neuroscience, UCL Institute of 
Neurology, London, UK), Fabrice Danjou (Institut du Cerveau et de la Moelle épinière, ICM, 
Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, 
AP-HP, Pitié-Salpêtrière Hospital, Paris, France), Faraz Faghri (Laboratory of Neurogenetics, 
National Institute on Aging, Bethesda, USA; Department of Computer Science, University of 
Illinois at Urbana-Champaign, Urbana, IL, USA), Gavin Charlesworth (Department of Molecular 
Neuroscience, UCL Institute of Neurology, London, UK), J Raphael Gibbs (Laboratory of 
Neurogenetics, National Institute on Aging, Bethesda, MD, USA; and Department of Molecular 
Neuroscience, UCL Institute of Neurology, London, UK), Huw R Morris (National Hospital for 
Neurology and Neurosurgery, University College London, London, UK), Helene Plun-Favreau 
(Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK), Dena G 
Hernandez (Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA; and 
Department of Molecular Neuroscience, UCL Institute of Neurology, London, UK), Peter Holmans 
(Biostatistics & Bioinformatics Unit, Institute of Psychological Medicine and Clinical 
Neuroscience, MRC Centre for Neuropsychiatric Genetics & Genomics, Cardiff, UK), Huw R Morris 
 3 
(National Hospital for Neurology and Neurosurgery, University College London, London, UK), Iris 
Jansen (VU University Medical Center, Amsterdam, Netherlands), John Hardy (Department of 
Molecular Neuroscience, UCL Institute of Neurology, London, UK), Javier Simón-Sánchez 
(Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, 
University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, 
Germany), Jose M Bras (Department of Molecular Neuroscience, UCL Institute of Neurology, 
London, UK), Joshua M. Shulman (Baylor College of Medicine, Houston, Texas, USA), John Quinn 
(Institute of Translational Medicine, University of Liverpool, Liverpool, UK), Juan A. Botía 
(Universidad de Murcia, Murcia, Spain), Kin Y Mok (Department of Molecular Neuroscience, UCL 
Institute of Neurology, London, UK), Kimberley Billingsley (Institute of Translational Medicine, 
University of Liverpool, Liverpool, UK), Lasse Pihlstrom (Department of Neurology, Oslo 
University Hospital, Oslo, Norway), Lea R’Bibo (Department of Molecular Neuroscience, UCL 
Institute of Neurology, London, UK), Codrin Lungu (National Institutes of Health Parkinson Clinic, 
NINDS, National Institutes of Health, Bethesda, MD, USA), Manu Sharma (Centre for Genetic 
Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tubingen 
and Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, 
University of Tübingen Germany), Maria Martinez (INSERM UMR 1220; and Paul Sabatier 
University, Toulouse, France), Mina Ryten (Department of Molecular Neuroscience, UCL Institute 
of Neurology, London, UK), Valentina Escott-Price (MRC Centre for Neuropsychiatric Genetics and 
Genomics, Cardiff University School of Medicine, Cardiff, UK), Niccolo E. Mencacci (Department 
of Molecular Neuroscience, UCL, London, UK), Mike A. Nalls (Laboratory of Neurogenetics, 
National Institute on Aging, Bethesda, USA; Contractor/consultant with Kelly Services, Rockville, 
MD, USA), Nicholas W Wood (UCL Genetics Institute; and Department of Molecular 
Neuroscience, UCL Institute of Neurology, London, UK), Patrick Lewis (University of Reading, 
Reading, UK), Paul Denny (University College London, London, UK), Peter Heutink (DZNE, German 
Center for Neurodegenerative Diseases and Department for Neurodegenerative Diseases, Hertie 
Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany), Patrizia Rizzu 
(DZNE, German Center for Neurodegenerative Diseases), Pille Taba (Department of Neurology 
and Neurosurgery, University of Tartu, Tartu, Estonia), Rita Guerreiro (Department of Molecular 
 4 
Neuroscience, UCL Institute of Neurology, London, UK), Ruth Lovering (University College 
London, London, UK), Raquel Duran Ogalla (University College London, London, UK), Rebecca 
Foulger (University College London, London, UK), Laurie Robak (Baylor College of Medicine, 
Houston, Texas, USA), Steven Lubbe (Ken and Ruth Davee Department of Neurology, 
Northwestern University Feinberg School of Medicine, Chicago, IL, USA), Steven Finkbeiner 
(Departments of Neurology and Physiology, University of California, San Francisco; Gladstone 
Institute of Neurological Disease; Taube/Koret Center for Neurodegenerative Disease Research, 
San Francisco, CA, USA), Sigurlaug Sveinbjörnsdóttir (Department of Neurology, Landspítali 
University Hospital, Reykjavík, Iceland; Department of Neurology, MEHT Broomfield Hospital, 
Chelmsford, Essex, UK; and Queen Mary College, University of London, London, UK), Andrew B 
Singleton (Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA), Sonja 
Scholz (Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders 
and Stroke, Bethesda, MD, USA), Sulev Koks (Department of Pathophysiology, University of Tartu, 
Tartu, Estonia), Suzanne Lesage (Institut du Cerveau et de la Moelle épinière, ICM, Inserm U 1127, 
CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, UMR S 1127, AP-HP, Pitié-
Salpêtrière Hospital, Paris, France), Jean-Christophe Corvol (Institut du Cerveau et de la Moelle 
épinière, ICM, Inserm U 1127, CNRS, UMR 7225, Sorbonne Universités, UPMC University Paris 06, 
UMR S 1127, Centre d’Investigation Clinique Pitié Neurosciences CIC-1422, AP-HP, Pitié-
Salpêtrière Hospital, Paris, France), Thomas Foltynie (UCL Institute of Neurology, London, UK), 
Thomas Gasser (Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain 
Research, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany), T. 
Ryan Price (University California Irvine, Irvine, CA, USA), Una-Marie Sheerin (Department of 
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 5 
COURAGE-PD Consortium members: 
ADD INFO HERE (Lasse will provide this information) 
 
 6 
Supplementary Figure 1. 
 
Comparison between NeuroX and NeuroChip HGMD phenotypes. The content of both NeuroX and NeuroChip was compared with 
the HGMD database (December, 2016). Phenotypes of included variants were binned in groups and compared between NeuroX and 
NeuroChip. Here you can see a clear increase in neurodegenerative disease content.
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Supplementary Figure 2.  
 
GenTrain scores of the NeuroChip separated by variant origin (backbone or custom content). 
Variants on the backbone are represented in red and variants on the custom content are 
represented by the blue line. This graph demonstrates high genotyping accuracy. 
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Supplementary Figure 3.  
 
GenTrain scores of the NeuroChip separated by variant origin (backbone or custom content) and divided by minor allele frequency. 
NeuroChip variant were divided in three group by minor allele frequency (MAF):  larger than 5%, between 5-1% and lower than 1%. 
Variants on the backbone are represented in red and variants on the custom content are represented by the blue line. 
 
Supplementary Table 2: Detailed, man
NeuroChip_variant_location_hg19
NeuroChip_variant_name
NeuroChip_variant_name_duplicates
HGMD_dbSNP_rsID
HGMD_record_ID
HGMD_Ref_Allele
HGMD_Alt_Allele
HGMD.Associated_disease/phenotype
HGMD.Mutation_Category
HGMD.Codon_Change
HGMD.Amino_Acid_Change
HGMD.Codon_Number
ANNO_Func.refGene
ANNO_Gene.refGene
ANNO_AAChange.refGene
ANNO_PopFreqMax
ANNO_SIFT_pred
ANNO_Polyphen2_HVAR_pred
ANNO_CADD_phred
 nually curated and annotated potential pathogen  
Location of the NeuroChip variant based on hg19 genome
Name of the NeuroChip variant
Names of the duplicate NeuroChip variant (when applicable)
dbSNP number obtained from HGMD database
Record number obtained from HGMD database
Reference allele obtained from HGMD database
Alternative allele obtained from HGMD database
Associated disease/phenotype obtained from HGMD database
Mutation category obtained from HGMD database -> e.g. splicing, in
Codon change obtained from HGMD database
Amino acide change obtained from HGMD database
Codon number that is changed due to variant obtained from HGMD 
Type of variant based on the annotated transcripts in RefSeq Gene f
Gene-name based on the annotated transcripts in RefSeq Gene from 
Amino acide change based on the annotated transcripts in RefSeq G
A database containing the maximum allele frequency from 1000G, E
SIFT scores -> D: Deleterious (sift<=0.05); T: tolerated (sift>0.05)
Polyphen2 HVAR scores -> D: Probably damaging (>=0.909), P: possi
Combined Annotation Dependent Depletion phred scores, scores hig
nic variant list
 ndel, missense
 database
 from ANNOVAR database -> e.g. splicing, indel, missense
 m ANNOVAR database 
 Gene from ANNOVAR database 
 ESP6500, ExAC and CG46 from ANNOVAR
 bly damaging (0.447<=pp2_hdiv<=0.909); B: benign (pp2_hdiv<=0.446)
 gher than 20 are considered potential pathogenic
Supplementary Table 3: List of discordant variants obt
10:5139687
11:133767899
11:63670220
11:63670247
11:63676752
11:88068238
12:109283244
12:111951190
12:123470588
12:40151737
12:41086492
12:49689409
12:49690766
13:101184390-101184390:C
13:111132722
13:111155774
13:48835397
149929426
14:105246549
14:51094956
14:55259736
15:44912596
15:60785863
15:62172815
15:62209881
15:62212695
15:62244054
15:62300961
15:62304326
15:62360405
16:15501683-15501683:C
16:18882730-18882730:C
16:30721388
16:30733985
16:57847634:indel
17:36707407
17:36707409
17:36707426
17:4849188
17:4851837
17:8050861
17:8053985
19:17766783
19:18109139
19:45408900
19:6413537
19:6416605
19:6416820
19:6416824
19:7618778
19:7618899
19:7626495
1:155101840
1:155242939
1:21044248
1:227058303
200610-150
200610-153
200610-175
200610-223
200610-251
200610-252
200610-280
200610-322
200610-330
200610-357
200610-365
200610-369
200610-374
200610-389
200610-393
2010-08-Y-1376
2010-08-Y-1599
2010-08-Y-160
2010-08-Y-1729
2010-08-Y-1730
2010-08-Y-1736
2010-08-Y-1815
2010-08-Y-1919
2010-08-Y-2053
2010-08-Y-2060
2010-08-Y-2109
2010-08-Y-213
2010-08-Y-250
2010-08-Y-2724
2010-08-Y-2853
2010-08-Y-2873
2010-08-Y-292
2010-08-Y-3253
2010-08-Y-928
20:3451825
20:4680104
20:56964361
20:56964380
20:56964467
20:56964484
20:61977663
20:61981100
20:62594091
20:62594107
21:34927489
22:29877014
22:29886815
22:30733726
22:41573633
22:41574976
22:42462742:G:T
2:169313290
2:171627402:C:A
2:74601381
3:150480627
3:52430897
4:15736067
4:23815446
4:23815926
4:77496889
4:967326
5:13814941
5:138653391
5:138658379
5:138665174
5:149786447
5:56177848
5:73205363
5:94805566
6:110098217
6:16328066
6:16761585
6:170871224
6:170881402
6:32363957
6:32485472
6:32485484
6:32485527
6:32487383
6:32917658
6:38738265
6:38749043
6:38810248
6:38893867
7:128480076
7:128480082
7:128480083
7:128480084
7:26233254
7:720260
7:720263
7:80302676
7:82450996
8:17132271
8:17137759
8:32621354
9:86284176
ENST00000265471:c.*4478C>A:
ENST00000394836:c.22C>A:p.Pro8Thr
ENST00000592274:n.1014C>T:
FAM8A1_ENST00000259963:c.644C>T:p.Ala215Val
FGF20_8:16859261_A>C
GATA4_8:11566407_G>A
JHkm_1_63070674_T_G
KDM6B_17:7751162_T>C
MUC16_ENST00000397910:c.40623T>G:p.Asp13541Glu
NOTCH3_Cys1099Tyr
NOTCH3_Cys144Ser
Neuro-19:17739976
Neuro-1:173503673
Neuro-1:198678805
Neuro-1:198691657
Neuro-1:198723580
Neuro-20:62119813
Neuro-5:140050907
PARK2:NM_004562.2:c.1051A>C:p.(Thr351Pro)
X:153218189
X:15804771
X:22855131
X:23934417
X:56591808
X:56591831
X:56591841
ZNF708_19:21477541_G>A
chia_chr2:32372329T>C
chia_chr7:30668286G>A
chq8:133900255:G_A
chr10:134981024:C_T
chr10:135012434:T_C
chr10:135015388:G_A
chr10:135025189:C_A
chr10:135033570:G_A
chr11:66619987:C_T
chr19:11326115:G_A
chr19:11333676:T_C
chr19:11364400:G_A
chr1:14108491:A_G
hrm_12_21446955_C_T
hrm_15_89862559_C_T
hrm_15_89868726_G_A
hrm_15_89876526_C_T
hrm_17_42427694_T_C
hrm_17_43195427_G_A
hrm_17_43227635_T_G
hrm_17_43319283_C_T
hrm_17_44108936_T_G
hrm_19_15290902_A_G
hrm_19_15290921_C_T
hrm_19_15290925_A_T
hrm_19_15291779_T_C
hrm_1_17313653_G_A
hrm_1_181058625_C_A
hrm_1_181058745_C_G
hrm_2_74598687_G_C
hrm_2_88895124_G_C
hrm_5_149435781_C_A
indel.108993
indel.37153
indel.86074
kgp1037316
kgp10891532
kgp12205482
kgp1740188
kgp1749507
kgp205168
kgp22163534
kgp22756960
kgp22768997
kgp22827913
kgp22832788
kgp29473677
kgp30522220
kgp30522236
kgp30552782
kgp31140559
kgp5731722
kgp6180196
kgp7509823
kgp9076500
kgp992657
qs137938320
qs145797672
rs10000358
rs10006644
rs10007533
rs10040287
rs10051358
rs10058439
rs10087581
rs10110117
rs10112384
rs10113339
rs10113595
rs10116017
rs10133227
rs10134526
rs10153456
rs10167662
rs10175001
rs1017682
rs10225672
rs10226317
rs1035709
rs10407807
rs10430768
rs10436793
rs1044397
rs1047043
rs10486701
rs10487220
rs10490754
rs1049518
rs10495244
rs10509631
rs10509831
rs10521280
rs1064253
rs10715770
rs10750695
rs10755996
rs10779060
rs10782582
rs10812525
rs10815578
rs10817689
rs10819389
rs10833683
rs10834253
rs10882712
rs10905673
rs10912140
rs10920369
rs10925579
rs10926188
rs10948512
rs10955639
rs10979834
rs10986490
rs11003807
rs11005326
rs11033374
rs11045891
rs1105179
rs11073052
rs11076320
rs11078432
rs11082325
rs11092802
rs11096435
rs11103556
rs11117946
rs111257756
rs111301507
rs11135373
rs111462568
rs111489110
rs1115936
rs111672807
rs111699303
rs11171161
rs1117491
rs1118523
rs11192848
rs111983365
rs11201928
rs112073343
rs112097634
rs112181933
rs112245337
rs112299063
rs11235292
rs112381236
rs11247259
rs112479210
rs112488600
rs112532213
rs11255499
rs112662115
rs112666974
rs112673227
rs112692398
rs112768156
rs112862174
rs11298541
rs11302795
rs113050156
rs113072895
rs113084031
rs113137473
rs113175509
rs113185531
rs113198522
rs113254230
rs113272531
rs113301313
rs113508957
rs113513525
rs113643703
rs11366304
rs113766983
rs113777099
rs113995889
rs113999621
rs114073742
rs114130949
rs114133038
rs114151420
rs114162318
rs114245908
rs114283106
rs114313697
rs114413724
rs114487350
rs114503963
rs114558047
rs114558519
rs114570133
rs114578432
rs114587182
rs114588017
rs114662567
rs114691114
rs114703506
rs114722435
rs114743179
rs1147909
rs114797655
rs114863996
rs114864685
rs114866229
rs114902511
rs115061451
rs115075606
rs115288980
rs115301786
rs115334001
rs115366579
rs115376840
rs115399820
rs115401398
rs115439983
rs115491410
rs115504840
rs115517707
rs115537306
rs115576187
rs115585643
rs115631208
rs115701969
rs11570507
rs115789198
rs115842053
rs115852120
rs115919272
rs115944290
rs11602122
rs116035935
rs1160534
rs11606391
rs11607288
rs11610720
rs116151828
rs11620941
rs116241306
rs116253116
rs11627133
rs116284182
rs116303897
rs116347024
rs116397156
rs116414589
rs11641981
rs116420016
rs116443016
rs116445125
rs116471159
rs11647309
rs116482553
rs116528713
rs11653110
rs116601361
rs116601642
rs11660588
rs1166757
rs116687253
rs116738104
rs116757529
rs11680075
rs116844930
rs116859565
rs116860002
rs116871905
rs116882698
rs116898019
rs116902847
rs11691306
rs116961307
rs116976316
rs116980703
rs116993696
rs117025390
rs117037675
rs117073615
rs117083468
rs117110990
rs117158379
rs11716943
rs117174103
rs11717579
rs11720451
rs117235813
rs117266269
rs117278649
rs117281669
rs117289073
rs117294911
rs117317700
rs117328936
rs117333786
rs11737315
rs117393863
rs117404109
rs11744650
rs117465505
rs117489697
rs117519370
rs117526438
rs11753155
rs117599182
rs117613526
rs117641964
rs11764433
rs117675369
rs117689540
rs117729848
rs117734952
rs117740871
rs117752254
rs117798692
rs117828339
rs117832982
rs11784473
rs117865143
rs117869281
rs117889128
rs117956750
rs117959934
rs117987258
rs11799086
rs11799120
rs11799140
rs11799187
rs11799224
rs11799228
rs11799282
rs118002984
rs118028621
rs118032444
rs118053872
rs11807408
rs11807437
rs11807757
rs118103136
rs118148882
rs11856607
rs11894798
rs11897664
rs11902209
rs11907268
rs11908507
rs11909447
rs1191697
rs1192701
rs11927156
rs11934657
rs11947112
rs11970612
rs11986050
rs11992219
rs11993184
rs11994955
rs11996955
rs12007311
rs12009109
rs12080108
rs12087474
rs1210347
rs12117200
rs12124153
rs12150660
rs121912277
rs121912497
rs12204802
rs12213463
rs12232985
rs12233495
rs12251346
rs12265105
rs12272716
rs12302890
rs12315731
rs12331778
rs12374070
rs12393627
rs12397014
rs12431732
rs12444341
rs12458578
rs12472953
rs12507316
rs12511057
rs12513464
rs12535929
rs12536442
rs12548451
rs12557044
rs12571998
rs12578842
rs12583344
rs1260606
rs12621616
rs12631770
rs12637221
rs12640699
rs12666009
rs12675573
rs12730058
rs12779790
rs1279585
rs12860022
rs1286809
rs12910968
rs12912021
rs12912762
rs12931725
rs12932333
rs12944658
rs12957300
rs12964156
rs12965777
rs13008912
rs13011184
rs13058910
rs13067039
rs13077764
rs13078931
rs13081253
rs13125208
rs13136632
rs13140166
rs13152636
rs1317376
rs1319209
rs13248943
rs13268269
rs13273445
rs13290518
rs13294991
rs13303383
rs13303422
rs13303445
rs13303468
rs13303533
rs13303607
rs13303707
rs13303737
rs13303739
rs13303766
rs13303851
rs13304073
rs13304193
rs13304202
rs13304209
rs13304248
rs13304337
rs13304342
rs13304385
rs13304523
rs13304526
rs13304527
rs13304570
rs13304723
rs13304869
rs13304877
rs13304924
rs13304959
rs13305061
rs13305133
rs13305207
rs13305221
rs13305251
rs13305277
rs13305427
rs13305470
rs13305543
rs13305548
rs13305876
rs13305939
rs1331359
rs13361467
rs1337278
rs13375516
rs13389628
rs13404970
rs13431994
rs13447372
rs1347729
rs1351800
rs1357719
rs1377666
rs137993245
rs1381315
rs138332475
rs138380184
rs138399323
rs138407486
rs138463923
rs138494049
rs138518669
rs138546275
rs138588445
rs138603987
rs138605787
rs138643966
rs138690889
rs138716614
rs138803384
rs138832022
rs138984751
rs139075178
rs139258100
rs139260617
rs139414038
rs139426631
rs139478757
rs139493285
rs139507795
rs139531511
rs139544472
rs139561256
rs139689087
rs139731099
rs139744336
rs139898369
rs139909551
rs139959956
rs139960770
rs140138929
rs140257520
rs140346824
rs140510330
rs140537553
rs140563811
rs140573357
rs140587580
rs140591579
rs140693948
rs140735925
rs140793159
rs140806002
rs140808085
rs140845794
rs140921219
rs140921826
rs140923623
rs141019354
rs141036312
rs141054329
rs141063662
rs141099047
rs141276592
rs141348817
rs141349006
rs141374152
rs141377089
rs141391611
rs141465623
rs1414721
rs141476869
rs141526960
rs141647784
rs141661699
rs141687469
rs141776251
rs141789763
rs141823111
rs141841525
rs141854092
rs141884753
rs142008817
rs142051621
rs142092095
rs142111601
rs142239264
rs142279499
rs142313786
rs142337022
rs142364804
rs142529742
rs142580410
rs142720026
rs142720356
rs142783685
rs142785565
rs142804635
rs142847456
rs142971560
rs143045885
rs1430555
rs143093439
rs143201132
rs143213712
rs143248983
rs143385744
rs143432155
rs143449501
rs143615613
rs143705823
rs143707229
rs143751739
rs143786622
rs143834490
rs143865753
rs143952294
rs144045813
rs144057068
rs144059059
rs144093990
rs144184935
rs1442272
rs144345434
rs144412147
rs144425692
rs144581282
rs1446208
rs144757233
rs145056526
rs145206960
rs145292556
rs145308383
rs145332698
rs145396090
rs145411186
rs145427757
rs145525549
rs145543236
rs1455698
rs145580348
rs145596649
rs145720635
rs145728021
rs1458012
rs145905497
rs145925165
rs145965013
rs146001276
rs146143774
rs146209191
rs146210059
rs146219118
rs146323693
rs146435621
rs146477727
rs146526477
rs146557235
rs1465648
rs146728374
rs146746976
rs146812788
rs146954194
rs147008916
rs147027853
rs147029990
rs147032728
rs147034369
rs147056571
rs147081725
rs147114106
rs147122280
rs147187210
rs147330727
rs147402252
rs147412364
rs147413669
rs147473037
rs147549717
rs147591861
rs147621525
rs147634318
rs147718924
rs147837343
rs1478999
rs147997216
rs148029283
rs148076892
rs148147276
rs148195237
rs1483455
rs148415802
rs148466998
rs148555776
rs148566591
rs148588811
rs148811656
rs148885277
rs148970873
rs1489948
rs149056614
rs149059705
rs149076105
rs149109195
rs149129987
rs149143483
rs149175031
rs149342102
rs149427945
rs149436504
rs1494508
rs149459161
rs149574008
rs1495978
rs149605512
rs149654844
rs149689831
rs149745899
rs149814760
rs149943670
rs150054275
rs150055328
rs150081819
rs150105750
rs150120415
rs150137665
rs150231434
rs150443398
rs150738600
rs150791589
rs150797312
rs150991478
rs151068469
rs151112032
rs151136998
rs151210736
rs1520527
rs1529068
rs1539051
rs1548332
rs1549351
rs1551201
rs1552678
rs1553629
rs1563806
rs1572077
rs1598185
rs1599110
rs1635357
rs1635488
rs16832764
rs16847823
rs16877926
rs16883363
rs16931225
rs16938823
rs16941635
rs16950122
rs16956993
rs16959273
rs16962096
rs16981340
rs16987956
rs17001536
rs17015406
rs17019602
rs17022720
rs17023008
rs17024071
rs17049978
rs17051917
rs17057348
rs17074963
rs17076034
rs1709657
rs17132819
rs17141409
rs17147335
rs17153501
rs17165377
rs17165697
rs17166975
rs17249854
rs17250121
rs17250535
rs17250901
rs17302066
rs17307245
rs17315772
rs17342230
rs17382996
rs17393131
rs17414041
rs17468526
rs17491082
rs17491368
rs17503233
rs17561441
rs1767017
rs17692753
rs17764150
rs17765485
rs180733585
rs180750366
rs180824888
rs181004551
rs181057130
rs181362199
rs181535376
rs1816566
rs1817569
rs181810103
rs1818193
rs181929885
rs181943590
rs182027479
rs182045456
rs182075487
rs182290078
rs182353578
rs182357217
rs182809966
rs182922705
rs183065684
rs183081227
rs183152442
rs183269510
rs183360067
rs183369906
rs183390378
rs183473748
rs183609580
rs183706909
rs183975
rs1839795
rs183994242
rs184061518
rs184215010
rs184269760
rs184317786
rs184363395
rs184419381
rs184445430
rs184763426
rs184836976
rs184962630
rs185035222
rs185118595
rs185118828
rs185177543
rs1853782
rs185505114
rs185559636
rs185589942
rs185629700
rs185704897
rs185733549
rs185798867
rs186005478
rs186049652
rs186515764
rs186539643
rs186545599
rs186608264
rs186633612
rs186688641
rs186860471
rs186923145
rs187045021
rs187245468
rs187328193
rs187364526
rs187380998
rs187392925
rs187411733
rs187437867
rs187568255
rs187613076
rs188370760
rs188562675
rs188581288
rs188653915
rs188683373
rs188868996
rs188934180
rs189126408
rs189274678
rs189321533
rs189415856
rs189518837
rs189570093
rs1895985
rs1896049
rs189658021
rs189675896
rs189764453
rs189794798
rs189870153
rs189897356
rs189931766
rs189970725
rs190164211
rs190165255
rs190567288
rs190581629
rs190605071
rs1906089
rs190786598
rs190951602
rs191024195
rs191235703
rs191336946
rs191528375
rs191547298
rs191573391
rs191606864
rs191714520
rs191726086
rs191747597
rs191747986
rs192046770
rs192181808
rs192258754
rs192371984
rs192384717
rs192417228
rs192464087
rs192597449
rs192640504
rs192829026
rs192869934
rs192969708
rs193095
rs193133422
rs193155786
rs193194244
rs1932431
rs1932458
rs193297321
rs1946168
rs1950699
rs1955318
rs1976384
rs1978110
rs1980023
rs199607597
rs199668642
rs199928676
rs199983052
rs200113661
rs200270655
rs200290759
rs200343375
rs200348413
rs200462490
rs200482299
rs200537416
rs200540407
rs200583770
rs200642243
rs200824392
rs2008521
rs200879808
rs200905292
rs201076120
rs201248925
rs201263728
rs201276250
rs201352503
rs201411753
rs201535427
rs201569297
rs2016098
rs201624085
rs201793160
rs201795784
rs201915236
rs202126411
rs2026056
rs2032592
rs2032600
rs2032603
rs2032613
rs2032614
rs2032650
rs2032661
rs2032664
rs2032671
rs205726
rs207291
rs2079742
rs2091667
rs209238
rs2097919
rs2100469
rs2108702
rs2115848
rs2120541
rs2120789
rs2129703
rs2130105
rs2145512
rs215428
rs2156391
rs2157258
rs2183767
rs2189849
rs2195603
rs2195911
rs2201163
rs2204974
rs2217063
rs2248956
rs225443
rs2256003
rs2268588
rs2284318
rs228437
rs2291062
rs2292063
rs2301071
rs2301393
rs2303115
rs2304316
rs2305016
rs2316958
rs2330341
rs2331282
rs2354806
rs2361009
rs2371706
rs2389380
rs2389963
rs239864
rs2402593
rs2408366
rs2408468
rs2434209
rs2453665
rs2457262
rs2459136
rs2469169
rs2469385
rs2472319
rs2496973
rs2519923
rs253152
rs2535124
rs2535609
rs2557333
rs2557549
rs2561531
rs2580150
rs2591161
rs2612183
rs2618063
rs2649078
rs2654657
rs2654715
rs2665572
rs267608364
rs267608594
rs267608595
rs2701669
rs2703825
rs2710058
rs2710584
rs271066
rs2717381
rs2719922
rs2727612
rs2735806
rs2772089
rs2800846
rs2803229
rs2829108
rs28365225
rs2837987
rs28406193
rs28469095
rs28475626
rs28560222
rs28563947
rs28583376
rs28641196
rs287070
rs28899189
rs2916718
rs2917324
rs2919026
rs291963
rs293180
rs2932538
rs2932690
rs29394
rs2965059
rs2966395
rs2968845
rs2982249
rs2992749
rs3096780
rs3096824
rs3096835
rs3097069
rs3097077
rs3102202
rs3116253
rs3121625
rs3131557
rs313233
rs313417
rs319290
rs325738
rs329545
rs331050
rs332157
rs33948978
rs33986910
rs34000971
rs34064949
rs34123918
rs34249039
rs34264001
rs34350256
rs34373446
rs34382085
rs344096
rs34427171
rs34555473
rs34630052
rs34640555
rs34688689
rs34692378
rs34727887
rs34769530
rs34814547
rs34864948
rs34890223
rs34921350
rs35067814
rs35101817
rs351345
rs35160044
rs35212659
rs35439383
rs35509584
rs35623864
rs35671167
rs35768544
rs35793787
rs35908490
rs35916069
rs35947883
rs367571121
rs367828849
rs367846696
rs368491387
rs368510162
rs368536466
rs368559431
rs368604683
rs369354524
rs369774032
rs369918757
rs369977653
rs370210871
rs370482937
rs370531078
rs370580349
rs371115939
rs371323911
rs371506665
rs371525654
rs371764755
rs372179834
rs372254901
rs372332342
rs372333946
rs372933281
rs373027395
rs373265565
rs373609364
rs373614443
rs373638033
rs3737334
rs373857348
rs374077765
rs374392668
rs3744097
rs3744805
rs374780126
rs375149463
rs375269518
rs375287882
rs375556342
rs375577851
rs375761697
rs376082058
rs376213352
rs376462300
rs376953984
rs377011729
rs377047353
rs377055573
rs377350079
rs3773827
rs377452600
rs377580761
rs3800506
rs3804765
rs3804849
rs3810492
rs3811072
rs3816553
rs3852091
rs38857
rs3887309
rs3896872
rs3897
rs3897767
rs3911999
rs3912
rs3967881
rs399350
rs4026601
rs4044313
rs4146182
rs4149087
rs415435
rs418144
rs422547
rs4241472
rs4260603
rs4271287
rs4284720
rs428538
rs4297228
rs4310385
rs433203
rs4333219
rs4339777
rs4343125
rs4367411
rs4410626
rs442882
rs4430236
rs4452539
rs4459278
rs4459600
rs4466326
rs4486086
rs4500722
rs4502102
rs4521633
rs45439595
rs4592522
rs4592538
rs4595281
rs4599990
rs4631143
rs4649988
rs4654601
rs4656784
rs4660378
rs4664561
rs4665867
rs4666814
rs4667681
rs4679397
rs4681391
rs4691953
rs4697814
rs4710928
rs4738862
rs474225
rs4744958
rs4747610
rs4748522
rs477992
rs479132
rs4791658
rs4792498
rs4804636
rs4832316
rs4850546
rs4867600
rs4872404
rs4890127
rs4910748
rs4910994
rs4993917
rs500840
rs531842
rs545862
rs55732312
rs55842018
rs55943169
rs55943756
rs55984533
rs55999805
rs56020668
rs560752
rs56138373
rs56160157
rs56220349
rs56223973
rs56224522
rs56311306
rs56356576
rs56783582
rs56925241
rs57291316
rs574989
rs5760645
rs5761664
rs57656430
rs580413
rs587949
rs5904923
rs5905455
rs5912393
rs5922838
rs592928
rs5942157
rs5942382
rs59584796
rs59594922
rs59629990
rs5968003
rs59681478
rs5969112
rs5970710
rs5972169
rs5976862
rs5980621
rs5986271
rs59877592
rs600455
rs6044994
rs60458744
rs60631746
rs6078410
rs608962
rs6093787
rs61749737
rs61753006
rs61836049
rs62075603
rs62075610
rs62077268
rs62077272
rs62188077
rs62257757
rs62270204
rs62275470
rs62362948
rs62516522
rs63749937
rs638715
rs6427504
rs6452716
rs6458580
rs6461483
rs6463905
rs6490689
rs6501001
rs6502998
rs6504745
rs6516899
rs6530626
rs6532200
rs6538610
rs6544527
rs6552386
rs6553317
rs6583698
rs6585026
rs6611148
rs6616776
rs6622268
rs6628258
rs6634275
rs6643013
rs6657011
rs66606877
rs6667605
rs6670304
rs6681438
rs6710703
rs67126394
rs67179988
rs6734172
rs6740748
rs6745751
rs67527018
rs6782442
rs6783450
rs67951068
rs679689
rs68052546
rs6813342
rs6816784
rs682211
rs6833249
rs6838700
rs6842288
rs6855522
rs6858772
rs6860060
rs6870276
rs6871636
rs6874374
rs6883938
rs6895442
rs6928832
rs6944672
rs6945231
rs6948797
rs6964725
rs6978284
rs6989030
rs6994608
rs7000782
rs7001569
rs703693
rs704326
rs7057775
rs7059273
rs7061098
rs7067423
rs7067441
rs7073590
rs7090989
rs7099093
rs71121783
rs71360044
rs71425956
rs71479161
rs71560750
rs71566025
rs7157378
rs71658409
rs7168639
rs7172316
rs717268
rs717851
rs7196470
rs719758
rs72038799
rs721540
rs7222956
rs723204
rs7234377
rs7241999
rs7254503
rs72561598
rs72563172
rs72655317
rs7266300
rs72673284
rs72675316
rs72676233
rs72677634
rs72682135
rs72682200
rs72687625
rs72687645
rs72713282
rs72720228
rs72758324
rs72767412
rs7277342
rs72774229
rs72774233
rs72781337
rs72790150
rs72796829
rs72800394
rs72803021
rs72806370
rs72846845
rs72860905
rs72869869
rs72940411
rs72949923
rs72961268
rs7297578
rs72991344
rs73001893
rs73032050
rs730771
rs7308154
rs73152841
rs73158544
rs73182639
rs7329746
rs7330720
rs7332524
rs73374522
rs7339163
rs73523125
rs73558982
rs73596852
rs736388
rs73702257
rs737393
rs73749500
rs73824424
rs741536
rs74275503
rs74348171
rs74398156
rs74440757
rs74496366
rs74502648
rs74548637
rs7454987
rs7460155
rs7461275
rs74652827
rs74697865
rs7474521
rs74749893
rs74890775
rs74961398
rs74966541
rs75022962
rs7505815
rs75067363
rs75115263
rs7516803
rs7521914
rs75223219
rs7522779
rs75398999
rs7546
rs7548866
rs75554720
rs75579177
rs75628670
rs75656528
rs7568035
rs7568931
rs7576701
rs75790419
rs75869689
rs7588567
rs75901268
rs75950479
rs76052637
rs76085403
rs76112485
rs76189412
rs7626907
rs7627289
rs76291931
rs7634053
rs76381558
rs7642327
rs7644078
rs7646203
rs76469788
rs764791
rs7655606
rs76583585
rs7659814
rs76598518
rs76601117
rs76608362
rs76614406
rs76625082
rs76778165
rs7679950
rs7688538
rs76887344
rs76898810
rs76910145
rs76915287
rs76929053
rs7697867
rs76989110
rs7710912
rs77115164
rs77134861
rs77136210
rs77140144
rs7717384
rs7722253
rs77270138
rs77283122
rs77319677
rs7732928
rs77353628
rs77356823
rs7738117
rs77443446
rs77445167
rs7748283
rs77491158
rs77501519
rs77509752
rs77520239
rs7752388
rs77524237
rs7756935
rs7760851
rs77642684
rs77659049
rs7769423
rs7771556
rs77741121
rs7778208
rs7782559
rs77896069
rs78102592
rs78108573
rs78113766
rs78131062
rs78250012
rs7826419
rs7826446
rs7830812
rs78308457
rs7831044
rs78312077
rs78450101
rs7845376
rs7847689
rs78485107
rs78509894
rs78543427
rs7854994
rs78564288
rs78701537
rs7874748
rs78792736
rs78805567
rs7882742
rs78848046
rs78913991
rs7892995
rs7893048
rs7893069
rs78962518
rs78966919
rs79095521
rs79104132
rs79135381
rs79163542
rs7919321
rs79241725
rs7927115
rs79324072
rs79332791
rs79423523
rs79442957
rs7973303
rs7974649
rs7975686
rs79757528
rs7976290
rs79889387
rs79889619
rs79918226
rs7992519
rs7992864
rs79951189
rs80008184
rs80100773
rs8012882
rs80199507
rs8020900
rs8022193
rs802252
rs80236132
rs80281474
rs80285483
rs80289718
rs80319286
rs80327054
rs80333132
rs803831
rs8039702
rs8050847
rs8051838
rs8071898
rs8082491
rs8087677
rs8094221
rs8122234
rs814672
rs8180734
rs829863
rs832668
rs843532
rs848013
rs850714
rs857533
rs858279
rs880242
rs884431
rs9077
rs909108
rs916847
rs9285894
rs9290708
rs9291942
rs9297399
rs9317607
rs9320442
rs9320939
rs9341279
rs9341314
rs9341317
rs9372948
rs9381570
rs9382958
rs9386302
rs9387957
rs9399137
rs9406606
rs9438021
rs9453167
rs9459301
rs9493282
rs9508085
rs951453
rs952100
rs9540172
rs9540724
rs9560180
rs957431
rs958844
rs958845
rs9589777
rs9598397
rs9615707
rs9616770
rs9626052
rs970966
rs973893
rs9743901
rs977851
rs978335
rs9785672
rs9785704
rs9785746
rs9785786
rs9785810
rs9785853
rs9785882
rs9785908
rs9785941
rs9785991
rs9786005
rs9786015
rs9786018
rs9786021
rs9786075
rs9786082
rs9786112
rs9786169
rs9786179
rs9786236
rs9786258
rs9786284
rs9786353
rs9786362
rs9786442
rs9786448
rs9786576
rs9786672
rs9786723
rs9786735
rs9786758
rs9786778
rs9786819
rs9786821
rs9786845
rs9786851
rs9786855
rs9786869
rs9786905
rs9813890
rs9814702
rs982503
rs9832959
rs9861551
rs9868988
rs9882957
rs988345
rs9918628
rs9918914
rs992642
rs9931684
rs993922
rs9953734
rs997542
rs9979663
rs998257
rs9997921
seq-ADES601
seq-ADES604
seq-prion1653
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variant.73621
variant.77278
variant.80031
 tained from the 15 technical replicates
Supplementary Table 4. APOE  genotype compa
FID
NeuroChip_ID The NeuroChip identifier
NABEC_ID The previously assigned NABEC ID based on (Hernande  
call_rate_(post_reclustering) Overall genotyping call rate
Gender Gender
Taqman APOE APOE allele status based on Taqman assay
NeuroChip APOE APOE allele status based on NeuroChip array
Comparison Comparison between the APOE allele genotypes
seq-rs429358-T2 Genotype call of probe seq-rs429358-T2, note that 0/0 
seq-rs429358-T3 Genotype call of probe seq-rs429358-T3, note that 0/0 
consensus_rs429358 Consensus of rs429358 based on seq-rs429358-T2 and 
rs7412 Genotype call of probe rs7412, note that 0/0 means th  
seq-rs7412-B1 Genotype call of probe seq-rs7412-B1, note that 0/0 m
seq-rs7412-B3 Genotype call of probe seq-rs7412-B3, note that 0/0 m
consensus_rs7412 Consensus of rs7412 based on rs7412, seq-rs7412-B1 a
arison between Taqman and NeuroChip array
z et al., 2012) and dbGAP record  phs000249
 0 means that no genotype was called
 0 means that no genotype was called
  seq-rs429358-T3
 at no genotype was called
 means that no genotype was called
 means that no genotype was called
 and seq-rs7412-B3
